These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 242206)

  • 21. Graft-versus-host reactions in mice. I. Kinetic and immunogenetic studies of alloantigen-sensitive units of lymphoid tissue.
    Bennett M
    Transplantation; 1971 Feb; 11(2):158-69. PubMed ID: 4397088
    [No Abstract]   [Full Text] [Related]  

  • 22. Specific unresponsiveness to skin allografts in mice. II. The mechanism of unresponsiveness induced by tissue extracts and antilymphocytic serum.
    Kilshaw PJ; Brent L; Thomas AV
    Transplantation; 1974 Jan; 17(1):57-69. PubMed ID: 4148889
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2----B10).
    Ildstad ST; Wren SM; Bluestone JA; Barbieri SA; Stephany D; Sachs DH
    J Immunol; 1986 Jan; 136(1):28-33. PubMed ID: 2933464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cytologic bases of immune responses.
    Turk JL
    Adv Biol Skin; 1971; 11():45-61. PubMed ID: 4950055
    [No Abstract]   [Full Text] [Related]  

  • 25. Unresponsiveness to rat cardiac allografts induced by intrathymic injection of donor bone marrow cells and short course of immunosuppression.
    Hara Y; Matsuura T; Imanishi M; Tahara H; Kurita T
    Transplant Proc; 1994 Dec; 26(6):3226-8. PubMed ID: 7527955
    [No Abstract]   [Full Text] [Related]  

  • 26. Pretreatment with antilymphocyte globulin and donor cells on graft prolongation in an experimental model and some observations on graft-versus-host reaction.
    Pegrum GD; Williams G; Markwick J; Barnes RM
    Postgrad Med J; 1976; 52(5 Suppl):47-50. PubMed ID: 11454
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thymus: an essential factor in lymphoid repopulation.
    Stutman O; Yunis EJ; Good RA
    Transplant Proc; 1969 Mar; 1(1):614-5. PubMed ID: 4400068
    [No Abstract]   [Full Text] [Related]  

  • 28. The use of donor-specific antigen for the induction of immunologic unresponsiveness to experimental and clinical allografts.
    Monaco AP; Wood ML; Maki T; Gozzo JJ; DeFazio S
    Transplant Proc; 1988 Feb; 20(1 Suppl 1):122-30. PubMed ID: 3279606
    [No Abstract]   [Full Text] [Related]  

  • 29. Cellular immunology and the pathogenesis of graft versus host reactions.
    Elkins WL
    Prog Allergy; 1971; 15():78-187. PubMed ID: 4151282
    [No Abstract]   [Full Text] [Related]  

  • 30. Graft-versus-host-induced immunosuppression. The effect of antigenic stimulation on cell-mediated and humoral immune responses.
    Treiber W; Lapp WS
    Transplantation; 1973 Sep; 16(3):211-6. PubMed ID: 4147031
    [No Abstract]   [Full Text] [Related]  

  • 31. An in vitro reaction between lymphoid cells and target fibroblastic cells: a possible model for in vivo rejection of haemopoietic allografts.
    Mayhew E; Bennett M
    Immunology; 1971 Jul; 21(1):123-36. PubMed ID: 4934136
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Persistence of cell-mediated cytotoxicity and serum blocking activity in highly tolerant rats.
    Wright PW; Bernstein ID; Hamilton B; Hellström KE
    Transplantation; 1975 May; 19(5):437-41. PubMed ID: 239476
    [No Abstract]   [Full Text] [Related]  

  • 33. Immunological enhancement of renal allografts.
    Stuart FP; McKearn TJ; Fitch FW
    Transplant Proc; 1974 Dec; 6(4 Suppl 1):53-8. PubMed ID: 4140597
    [No Abstract]   [Full Text] [Related]  

  • 34. Hemopoietic inductive envirnment necessary for an early stage in differentiation of thymic immune cells: effect of antilymphocytic serum.
    Bennett M
    J Cell Physiol; 1972 Apr; 79(2):309-16. PubMed ID: 4402104
    [No Abstract]   [Full Text] [Related]  

  • 35. Bone marrow transplantation incompatibility modified by F 1 graft inocula.
    Chee CA; Ilbery PL; Motta R
    Rev Eur Etud Clin Biol; 1972 Jan; 17(1):53-65. PubMed ID: 4402804
    [No Abstract]   [Full Text] [Related]  

  • 36. [Bone marrow regulatory factors (BMRF) and the transplanting of bone marrow: a model of morphostasis and immunity].
    Pierpaoli W; Maestroni GJ
    Fiziol Cheloveka; 1984; 10(2):234-41. PubMed ID: 6398233
    [No Abstract]   [Full Text] [Related]  

  • 37. Allograft enhancement induced by bone marrow cells.
    Liegeois A; Charreire J; Brennan LB
    Surg Forum; 1974; 25(0):297-300. PubMed ID: 4612783
    [No Abstract]   [Full Text] [Related]  

  • 38. Bone marrow transplantation in rats across strong histocompatibility barriers by selective elimination of lymphoid cells in donor marrow.
    Müller-Ruchholtz W; Wottge HU; Müller-Hermelink HK
    Transplant Proc; 1976 Dec; 8(4):537-41. PubMed ID: 11584
    [No Abstract]   [Full Text] [Related]  

  • 39. Relative strength of the male-specific antigen.
    Polácková M; Rejzková J; Viklický V
    Folia Biol (Praha); 1970; 16(6):381-4. PubMed ID: 4394678
    [No Abstract]   [Full Text] [Related]  

  • 40. Non-specific and adaptive immunity in renal transplantation.
    Alexander JW; McCoy HV; Phair JP; Altemeier WA
    Transplant Proc; 1969 Mar; 1(1):283-6. PubMed ID: 4944227
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.